Remove 2011 Remove Doctors Remove Fraud
article thumbnail

California Doctor to Pay over $9.48M, Sentenced to Prison, to Settle Fraud Allegations

Med-Net Compliance

California Attorney General Rob Bonta announced a settlement against a Southern California doctor for submitting false claims to Medicare and Medi-Cal between the years of 2011 and 2018 for drugs, procedures, services, and tests that were never administered to patients. The doctor?is?an The case was ? in October 2017?under

Fraud 59
article thumbnail

Former Outcome Health Execs Sentenced in $1B Fraud Scheme

HIT Consultant

Rishi Shah, co-founder and former CEO of Outcome Health What You Should Know: – Three former executives of Outcome Health, a Chicago-based health tech startup, were sentenced for their roles in a massive fraud scheme that defrauded clients, lenders, and investors of an estimated $1B. Securities and Exchange Commission.

Fraud 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Healthcare Data Breach Statistics

HIPAA Journal

Josephs Medical Center $80,000 Settlement 2023 Doctors Management Services $100,000 Settlement 2023 L.A. 1,000,000 Settlement 2011 University of California at Los Angeles Health System $865,500 Settlement 2010 Rite Aid Corporation $1,000,000 Settlement 2010 Management Services Organization Washington Inc. 30,000 Settlement 2022 B. .

HIPAA 109
article thumbnail

CMS BLOG: Medicare for All? Just another name for a government-run, single payer system

CMS.gov

Medicare has a plethora of misaligned financial incentives that work to increase costs for taxpayers and beneficiaries, and create challenges related to fraud and abuse. Just look at the decreasing numbers of doctors. percent from 2011-2016, from $17.6 billion to $28.0 It’s time to move to a patient-centered, value-based system.

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

2023) ( Buckman preemption barred MDL asserting fraud on EPA), cert. Since the FDA requires pre-approval of any warnings about off-label uses, preemption at some point should have been pre-ordained under the Mensing ( 2011+1 ) independence principle, but off-label use did not really figure in Zofran ’s analysis. Monsanto Co. ,

FDA 105
article thumbnail

Another RICOdiculous Decision

Drug & Device Law

Nonetheless, the Ninth Circuit’s PATDC82 I allowed a RICO claim alleging that, between 1999 and 2011, defendants concealed that risk from the FDA and that, as a result, every TPP in the country paid for Actos prescriptions that it otherwise would not have reimbursed. The federal rules don’t treat fraud that way. 1 (highlights).

Fraud 52
article thumbnail

Agree To Disagree – Don’t  Sue the Other Side of a Scientific Dispute into Silence

Drug & Device Law

Criticizing attempts to sue publishers of scientific content, here in 2011, and again, here in 2013. Scientific literature about the risks and benefits of prescription medical products does not – at least in the absence of academic fraud such as the actual falsification of data (see, here ) – subject the speaker to tort liability.